BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

New Report by BioTrends Explores the Unmet Need for Treatments Related to Proliferative and Non-Proliferative Glomerulonephritis


12/28/2011 6:37:55 AM

EXTON, Pa.--(BUSINESS WIRE)--Results of a survey of 100 U.S. nephrologists suggest that the need for new therapies targeted at glomerulonephritis (GN) is extremely high, with only polycystic kidney disease having significantly higher unmet need.

Nephrologists estimate that close to 10% of the patients they are managing have GN with focal segmental glomerulosclerosis (FSGS), membranous nephritis and IgA nephropathy accounting for approximately two-thirds of the cases. FSGS was associated with the highest unmet need resulting from a lack of effective treatments coupled with a high proportion of patients that are refractive to available treatments. Although they are fewer in number, patients with Goodpasture’s or blood vessel diseases (such as Wegener’s and vasculitis) are more likely to have rapid progression of chronic kidney disease, making treatment more urgent.


Read at BioSpace.com

BioTrends
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES